Healthcare, Regulatory and Reimbursement Market Opportunity, Segmentation and Forecast
- Submitted by: Marketreport
- Views: 50
- Category: Other
- Date Submitted: 05/16/2016 09:47 PM
- Pages: 4
- Report this Essay
Summary
GlobalData, the industry analysis specialist, has released its new report, CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - UK. The report is an essential source of information and an analysis on the healthcare, regulatory and reimbursement landscape of the UK. The report identifies the key trends in the healthcare market and provides insights on the demographic, regulatory, reimbursement landscape and healthcare infrastructure of the UK. Most importantly, the report provides valuable insights on the trends and segmentation of the pharmaceutical and medical devices market. This report is built using data and information sourced from proprietary databases, secondary research and in-house analysis by GlobalDatas team of industry experts.
Browse Detail Report With TOC @ https://marketreportscenter.com/reports/139022/countryfocus
Scope
In 2014, the UK`s population was approximately 64.2 million. The major factors contributing to the growth in the population are increase in net migration and decrease in death rate. The UK policymakers are now presented with the problems of a Eurozone crisis, a declining population of the working age group and an increasing elderly population. The pharmaceutical market in the UK was estimated at $28.8 billion in 2015 and is expected to reach approximately $43.2 billion by 2020 with a projected Compound Annual Growth Rate (CAGR) of 8.4%. The medical devices market size was approximately $14.4 billion in 2015 and is expected to reach approximately $17.9 billion by 2020 with a projected CAGR of 4.5%.
The positive trends in the UK healthcare market can be attributed primarily to –
- Increasing elderly population
- Universal healthcare insurance
- High degree of access to healthcare facilities
Scope
The report provides information on the healthcare, regulatory and reimbursement landscape of the UK. The scope includes –
- Overview of the pharmaceutical and...
GlobalData, the industry analysis specialist, has released its new report, CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - UK. The report is an essential source of information and an analysis on the healthcare, regulatory and reimbursement landscape of the UK. The report identifies the key trends in the healthcare market and provides insights on the demographic, regulatory, reimbursement landscape and healthcare infrastructure of the UK. Most importantly, the report provides valuable insights on the trends and segmentation of the pharmaceutical and medical devices market. This report is built using data and information sourced from proprietary databases, secondary research and in-house analysis by GlobalDatas team of industry experts.
Browse Detail Report With TOC @ https://marketreportscenter.com/reports/139022/countryfocus
Scope
In 2014, the UK`s population was approximately 64.2 million. The major factors contributing to the growth in the population are increase in net migration and decrease in death rate. The UK policymakers are now presented with the problems of a Eurozone crisis, a declining population of the working age group and an increasing elderly population. The pharmaceutical market in the UK was estimated at $28.8 billion in 2015 and is expected to reach approximately $43.2 billion by 2020 with a projected Compound Annual Growth Rate (CAGR) of 8.4%. The medical devices market size was approximately $14.4 billion in 2015 and is expected to reach approximately $17.9 billion by 2020 with a projected CAGR of 4.5%.
The positive trends in the UK healthcare market can be attributed primarily to –
- Increasing elderly population
- Universal healthcare insurance
- High degree of access to healthcare facilities
Scope
The report provides information on the healthcare, regulatory and reimbursement landscape of the UK. The scope includes –
- Overview of the pharmaceutical and...